Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry

Birmingham, Alabama

doi:10.1016/s0015-0282(00)01559-4

Cited by 85 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Assisted reproductive technology is defined as treatment in which eggs or embryos are handled for the purpose of achieving pregnancy. In the US, the number of fertility treatments and fertility treatment–conceived births has increased steadily since the early 1980s . At present, approximately 2% of pregnancies are conceived through ART, and its use has been increasing in recent years .…”

Section: Introductionmentioning

confidence: 99%

Association of Preterm Singleton Birth With Fertility Treatment in the US

et al. 2022

View full text Add to dashboard Cite

IMPORTANCEPreterm birth is a global health issue. The association between fertility treatment and preterm singleton births has not been clarified. OBJECTIVE To examine the association between fertility treatment and preterm birth. DESIGN, SETTING, AND PARTICIPANTS This population-based cohort study used birth data that were submitted by 50 states and the District of Columbia to the National Vital Statistics System database. All mothers in the database who had a singleton live birth from January 1, 2016, to December 31, 2019, were included. Those who had preexisting hypertension or diabetes were excluded. EXPOSURES Fertility treatment categorized as assisted reproductive technology (ART) or non-ART treatment. MAIN OUTCOMES AND MEASURESThe main outcome was a diagnosis of preterm birth, which was defined as birth before 37 complete weeks (<259 days) of gestation. Gestational age was calculated by obstetric estimation at delivery and was collected from the database. RESULTSThe final sample consisted of 14 370 920 mothers (mean [SD] age, 28.79 [5.79] years) with singleton live births. Of these women, 122 944 (0.9%) conceived by ART and 71 176 (0.5%) received non-ART treatment. The prevalence of preterm birth was 7.6% (n = 1 071 994) in natural conception, 10.7% (n = 13 205) in ART, and 9.3% (n = 6629) in non-ART groups. Compared with neonates who were naturally conceived, newborns who were conceived with ART (adjusted risk difference [aRD], 3.10% [95% CI, 2.93%-3.27%]; adjusted odds ratio [aOR], 1.49 [95% CI, 1.46-1.52]; P < .001) and non-ART treatment (aRD, 2.22% [95% CI, 2.00%-2.44%]; aOR, 1.35 [95% CI,; P < .001) had significantly higher risk for preterm birth after full adjustment. These associations were similar in subgroups of participants as defined by baseline characteristics.CONCLUSIONS AND RELEVANCE This study found that singleton neonates who were conceived by fertility treatment had higher rates of preterm birth. Further investigations are warranted into the association between ART or non-ART treatment and the risk of preterm birth in singleton neonates.

show abstract

Section: Introductionmentioning

confidence: 99%

Association of Preterm Singleton Birth With Fertility Treatment in the US

et al. 2022

View full text Add to dashboard Cite

show abstract

Preimplantation genetic diagnosis for chromosome abnormalities

Munné¹

2005

Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics

View full text Add to dashboard Cite

Preimplantation genetic diagnosis (PGD) is the earliest form of prenatal diagnosis and has been used in over 5000 infertile patient procedures to improve pregnancy outcome for in vitro fertilization (IVF). PGD has also been used to limit spontaneous abortions and chromosomally unbalanced or aneuploid offspring in patients of advanced maternal age or carriers of translocations or other chromosome abnormalities.

show abstract

In vitro fertilisation for unexplained subfertility

Pandian

Bhattacharya

Nikolaou

et al. 2002

The Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Background One-third of subfertile couples have no identifiable cause for their inability to conceive. In vitro fertilisation (IVF) is a widely accepted treatment for this condition; however, this treatment is invasive and expensive and is associated with risks. Objectives To evaluate the effectiveness and safety of IVF compared with expectant management, unstimulated intrauterine insemination (IUI) or intrauterine insemination along with ovarian stimulation with gonadotropins (IUI + gonadotropins) or clomiphene (IUI + CC) or letrozole (IUI + letrozole) in improving pregnancy outcomes.

show abstract

Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry

Cited by 85 publications

References 9 publications

Association of Preterm Singleton Birth With Fertility Treatment in the US

Association of Preterm Singleton Birth With Fertility Treatment in the US

Preimplantation genetic diagnosis for chromosome abnormalities

In vitro fertilisation for unexplained subfertility

Contact Info

Product

Resources

About